State of Tennessee, Department of Treasury’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $270K | Sell |
11,279
-16,640
| -60% | -$398K | ﹤0.01% | 1543 |
|
|
2025
Q1 | $694K | Buy |
27,919
+1,739
| +7% | +$43.2K | ﹤0.01% | 1283 |
|
|
2024
Q4 | $493K | Buy |
26,180
+3,264
| +14% | +$61.5K | ﹤0.01% | 1434 |
|
|
2024
Q3 | $345K | Sell |
22,916
-322
| -1% | -$4.85K | ﹤0.01% | 1512 |
|
|
2024
Q2 | $665K | Hold |
23,238
| – | – | ﹤0.01% | 1317 |
|
|
2024
Q1 | $679K | Sell |
23,238
-4,744
| -17% | -$139K | ﹤0.01% | 1289 |
|
|
2023
Q4 | $944K | Sell |
27,982
-2,099
| -7% | -$70.8K | ﹤0.01% | 1213 |
|
|
2023
Q3 | $923K | Hold |
30,081
| – | – | ﹤0.01% | 1084 |
|
|
2023
Q2 | $1.21M | Buy |
30,081
+6,200
| +26% | +$248K | 0.01% | 1082 |
|
|
2023
Q1 | $975K | Buy |
23,881
+6,431
| +37% | +$262K | ﹤0.01% | 1128 |
|
|
2022
Q4 | $674K | Sell |
17,450
-9,103
| -34% | -$352K | ﹤0.01% | 1249 |
|
|
2022
Q3 | $1.41M | Buy |
26,553
+4,693
| +21% | +$250K | 0.01% | 957 |
|
|
2022
Q2 | $1.28M | Buy |
21,860
+5,209
| +31% | +$304K | 0.01% | 994 |
|
|
2022
Q1 | $1.27M | Sell |
16,651
-4,196
| -20% | -$320K | ﹤0.01% | 1082 |
|
|
2021
Q4 | $1.25M | Buy |
20,847
+4,131
| +25% | +$248K | ﹤0.01% | 1055 |
|
|
2021
Q3 | $937K | Sell |
16,716
-1,505
| -8% | -$84.4K | ﹤0.01% | 1156 |
|
|
2021
Q2 | $1.11M | Buy |
18,221
+2,588
| +17% | +$157K | ﹤0.01% | 1125 |
|
|
2021
Q1 | $1.1M | Buy |
15,633
+219
| +1% | +$15.4K | ﹤0.01% | 1083 |
|
|
2020
Q4 | $922K | Sell |
15,414
-4,089
| -21% | -$245K | ﹤0.01% | 1097 |
|
|
2020
Q3 | $1.17M | Sell |
19,503
-6,828
| -26% | -$411K | 0.01% | 894 |
|
|
2020
Q2 | $1.38M | Sell |
26,331
-6,096
| -19% | -$320K | 0.01% | 838 |
|
|
2020
Q1 | $1.09M | Buy |
32,427
+2,417
| +8% | +$81K | 0.01% | 876 |
|
|
2019
Q4 | $1.36M | Buy |
+30,010
| New | +$1.36M | 0.01% | 945 |
|
|
2019
Q1 | – | Sell |
-1,602
| Closed | -$69K | – | 1632 |
|
|
2018
Q4 | $69K | Buy |
+1,602
| New | +$69K | ﹤0.01% | 1534 |
|